Study of relation of serum magnesium with complications in type 2 diabetes mellitus

 

 

 REFERENCES

1. J. Larry Jameson, Dennis L. Kasper, Dan L. Longo, Anthony S. Fauci, Stephen L. Hauser, Joseph Loscalzo, Harrison’s principles of internal medicine, 20th ed. New Delhi: Mc Graw Hill; 2012
2. Church V. Economic costs of diabetes in the US in 2002. Diabetes care. 2003 Mar;26(3):917-32.
3. Huizinga MM, Rothman RL. Addressing the diabetes pandemic: A comprehensive approach. Indian Journal of Medical Research. 2006 Nov 1;124(5):481.
4. Sarwar N, Gao P, Seshasai SR. Diabetes mellitus, fasting blood glucose concentration, and risk of vascular disease [published correction appears in Lancet. 2010; 376 (9745): 958]. Lancet. 2010;375(9733):2215-22.
5. Gale J. India’s Diabetes Epidemic Cuts Down Millions Who Escape Poverty. November 7, 2010. Bloomberg Markets Magazine.
6. McKeigue PM, Shah B, Marmot MG. Relation of central obesity and insulin resistance with high diabetes prevalence and cardiovascular risk in South Asians. The Lancet. 1991 Feb 16;337(8738):382-6.
7. Mohan V, Sharp PS, Cloke HR, Burrin JM, Schumer B, Kohner EM. Serum immunoreactive insulin responses to a glucose load in Asian Indian and European type 2 (non-insulin-dependent) diabetic patients and control subjects. Diabetologia. 1986 Apr 1;29(4):235-7.
8. Zargar AH, Wani AI, Masoodi SR, Laway BA, Bashir MI. Mortality in diabetes mellitus—data from a developing region of the world. Diabetes research and clinical practice. 1999 Jan 1;43(1):67-74.
9. Mohan V, Deepa R, Rani SS, Premalatha G. Prevalence of coronary artery disease and its relationship to lipids in a selected population in South India: The Chennai Urban Population Study (CUPS No. 5). Journal of the American College of Cardiology. 2001 Sep 1;38(3):682-85
10. Premalatha G, Shanthirani S, Deepa R, Markovitz J, Mohan V. Prevalence and risk factors of peripheral vascular disease in a selected South Indian population: the Chennai Urban Population Study. Diabetes care. 2000 Sep 1;23(9):1295-300.
11. Melton LJ, Kathleen MM, Palumbo PJ, Elveback LR. Incidence and prevalence of clinical peripheral vascular disease in a population-based cohort of diabetic patients. Diabetes care. 1980 Nov 1;3(6):650-4.
12. Bherwani S, Jibhkate SB, Saumya AS, Patel SK, Singh R, Ghotekar LH. Hypomagnesaemia: a modifiable risk factor of diabetic nephropathy. Hormone molecular biology and clinical investigation. 2017 Mar 1;29(3):79-84.
13. Sharma A, Dabla S, Agrawal RP, Barjatya H, Kochar DK, Kothari RP. Serum magnesium: an early predictor of course and complications of diabetes mellitus. Journal of the Indian Medical Association. 2007 Jan;105(1):16-8.
14. Kundu D, Osta M, Mandal T, Bandyopadhyay U, Ray D, Gautam D. Serum magnesium levels in patients with diabetic retinopathy. J Nat Sci Biol Med. 2013 Jan;4(1):113-6.
15. Kumar P, Bhargava S, Agarwal PK, Garg A, Khosla A. Association of serum magnesium with type 2 diabetes mellitus and diabetic retinopathy. Journal of Family Medicine and Primary Care. 2019 May;8(5):1671.
16. Giugliano D, Russo PD, Passariello N. Hypomagnesemia in relation to diabetic retinopathy. Diabetes Care. 1982 Sep 1;5(5):558-9.